Journal of Medicinal Chemistry · 2011 · 200 citations · 25 references
Natural SciencesChemistryMedicinal ChemistryCancer PharmacologyDrug DiscoveryMolecular OncologyBioinorganic ChemistryCoordination ChemistryEnzyme InhibitionMetal-ligand BondingTopoisomerase InhibitorsTransition Metal ComplexesAntiproliferative AgentsAntiproliferative Drug ActionCatalytic Topoisomerase InhibitionDna Topoisomerase Ii InhibitionTopoisomerase Ii Inhibitors
The topoisomerase-IIα inhibition and antiproliferative activity of α-heterocyclic thiosemicarbazones and their corresponding copper(II) complexes have been investigated. The Cu(II)(thiosemicarbazonato)Cl complexes were shown to catalytically inhibit topoisomerase-IIα at concentrations (0.3-7.2 μM) over an order of magnitude lower than their corresponding thiosemicarbazone ligands alone. The copper complexes were also shown to inhibit the proliferation of breast cancer cells expressing high levels of topoisomerase-IIα (SK-BR-3) at lower concentrations than cells expressing lower levels of the enzyme (MCF-7).
25
Johnny Easmon, Gerhard Pürstinger, Gottfried Heinisch et al. · Journal of Medicinal Chemistry · 2001 · 255 citations
Patric J. Jansson, Philip C. Sharpe, Paul V. Bernhardt et al. · Journal of Medicinal Chemistry · 2010 · 241 citations